Study Complete
Sponsor ID
20130139
Study to Assess the Safety and Tolerability of Single Ascending Doses of KAI-4169 in Hemodialysis Subjects with Secondary Hyperparathyroidism
Study Details
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Study Documents
Study Synopsis
Available Language(s): English
Locations
No locations found.